Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2006.102 | Liraglutide Effect and Action in Diabetes (LEAD-1): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Glimepiride Versus Glimepiride Monotherapy Versus Glimepiride and Rosiglitazone Combination Therapy in Subjects with Type 2 Diabetes. A Six-Month Double-blind, Double-dummy, Randomised, Active Control, Parallel-group, Multi-Centre, Multi-National Trial | Dr. Chow C.C. Francis |
| 2006.117 | A Randomized, Single-blind, Parallel Group Pilot Study on the Use of NARL-Sonic Treatment to Induce Fat Mobilization and Visceral Fat Reduction | CHOW CC Francis |
| 2006.335 | A Single Centre, Open-Labeled Observational Study on the Efficacy of Benfotiamine in the Treatment of Painful Diabetic Neuropathy | CHOW CC Francis |
| 2006.137 | Sandostatin LAR OASIS (Obersvational Acromegaly Study on Impact of Sandoststin LAR) - An Observational, Multicenter Study on the Impact Therapeutics Decision Making for Recently Diagnosed Acromegalic Patients with Microadenomas or Macrodenomas Prescribed | CHOW CC Francis |
| 2010.137 | BEGIN | Dr. Chow Chun Chung |
| 2003.020 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-0767 Added to Metformin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus | Dr. Chow Chun Chung Francis |
| 2005.001 | A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Long-Term Effect (up to 5 Years) of Treatment with LAF237 50 mg Bid to Glimepiride up to 6 mg Daily as Add-On Therapy in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy | Dr. Chow Chun Chung Francis |
| 2002.393 | Muticentre, Open, Uncontrolled Clinical Extension Trial of HOE901 in Type I and 2 Diabetes Patients Who Previously Participated in HOE901 Clinical Studies: HOE901/4034 Ref No. CRE-2002.393-t (Revised : CRE-2002.069-t) | Prof. Chow Chun Chung Francis |
| 2003.266 | An International, Randomized, Open-Labelled Parallel Group Four Months Comparison of Basal Bolus Treatment with Insulin Aspart including NPH and Biphasic Insulin Aspart Formulations in Sujects with Type 2 Diabetes | Dr. Chow Chun Chung Francis |
| 2005.095 | A Randomized, Open-labeled, Parallel, Comparative Study of the Efficacy and Tolerability of Rosuvastatin in LDL-C Reduction Using Different Dosing Regimes of 5mg Daily, 10mg Daily and 10mg Alternate day in Hong Kong Chinese Type 2 Diabetic Patients | Dr. Chow Chun Chung Francis |
| 2003.111 | A Randomized, Double Blind, Placebo Controlled Trial on the Effect of Rosiglitazone in Reversion of Newly Diagnosed Type 2 Diabetes to Non-Diabetic Status | Prof. Chow Chun Chung Francis |
| 2002.103 | A 6 Month Extension Of A Double-Blind Double-Dummy Multi-Centre Pararrel Group Trial Evaluating Long Term Efficacy And Safety Of NNC61-0029 In Combination With Glibenclamide vs Glibenclamide Monotherapy- - - Treatment of Subjects With Type 2 Diabetes | Dr. Chow Chun Chung Francis |
| 2009.458 | A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Adminstered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus | Dr. Chow Chun Chung Francis |
| 2003.021 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK-0767 Added to Sulfonylurea in Patients with Inadequately Controlled Type 2 Diabetes Mellitus | Dr. Chow Chun Chung Francis |
| 2002.328 | A Randomized, Multi-centre, Double-blind, Double-dummy, Parallel Group Trial of Two Doses of NNC 61-0029 in Combination with Glibenclamide Versus Glibenclamide Monotherapy and Versus Combination Therapy of Glibenclamide and Metformin in the Treatment of Subjects with Type 2 Diabetes | Dr. Chow Chun Chung Francis |
| 2002.333 | A Multinational, Randomized, Double-blind, Placebo-controlled, Forced-titration, 2 x 2 Factorial Design Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (IGT) | Dr. Chow Chun Chung Francis |
| 2003.025 | A Six Months, Multi-Centre, Open, Randomized, Parallel Safety and Efficacy Comparison of Actrapid ® Produced by the Current Process and Human Insulin with the Same Formulation as Actrapid ®, Produced by the NN729 Process in Subjects with Type 1 Diabetes on a Basal/ Bolus Regimen ( NN729-1541, Phase IIIb) | Dr. Chow Chun Chung Francis |
| 2003.263 | A 24 Weeks, Multi-Centre, Randomized, 2-Arm Parallel, Open-Labelled Study to Investigate the Efficacy and Safety of Initiating Biphasic Insulin Aspart 30 (BIAsp 30) in Type 2 Diabetes Patients Currently Not Achieving Treatment Targets with Oral Anti-Diabetes Drugs Alone (BIAsp-3021, Phase IV) | Dr. Chow Chun Chung Francis |
| 2005.257 | A 2-Year Study to Assess the Efficacy, Safety, and Tolerability of Taranabant in Obese Patients Followed by a 1-Year Extension | Dr. Chow Chun Chung Francis |
| 2007.303 | Having First-Degree Relative(s) with Osteoporsis will Affect Knowledge, Risk Perception and Preventive Behaviors of Women Toward this Disease? | CHOW Ka Man |
| 2004.111 | Treatment Strategy of Sevelamer in Peritoneal Dialysis Patients | Dr. Chow Ka Ming |
| 2005.202 | Assessing Sexual Functioning amongst Hong Kong Chinese Patients witih Gynaecological Cancer: the Translation and Validation of Sexual Function-Vaginal Changes Questionnaire | CHOW Ka Ming |
| 2006.196 | Polymorphisms in the OCTN 1/2 and DLG5 Genes in the Chinese Inflammatory Bowel Disease Patients | CHOW Kai Lai |
| 2006.195 | The Epidemiology Study of Inflammatory Bowel Disease in the Chinese Population | CHOW Kai Lai |
| 2006.062 | A Prospective Comparison between Small Bowel Follow-through, CT Enteroclysis and Capsule Endoscopy in Crohn's Disease | CHOW Kai Lai |
| 2005.134 | Does Extra-High Dose Hepatitis B Vanccination Confer Longer Serological Protection in Peritoneal Dialysis Patients? | CHOW Kai Ming |
| 2011.482 | A Study on the Quality of Prescriptions by Review of Medication Administration Records | CHOW Kai Ming |
| 2004.431 | A Local Study of the Relationship between Violent Behaviour and Metal Disorder (Dissertation Protocol for FHKCPsych-PartIII Examination 2005) | CHOW Kit Wan Kavin |
| 2004.340 | Stigma Towards Patients with Mental Illness Among General Hospital Healthcare Workers in Hong Kong (A dissertation project for the part III fellowship examination of the Hong Kong College of Psychiatrists) | CHOW Lai Yin |
| 2005.315 | Factors Influencing the Success of Ambulatory Chemotherapy for Colorectal Cancer Patients in the Prince of Wales Hospital | CHOW Mong Lai Dawnis |
| 2005.225 | Comparing the Different Stretching Methods on the Knee Range in People with Total Knee Replacement | CHOW Pui Yee |
| 2005.455 | Clinical Bioequivalence Study on Two Diazepam Formulations | Prof. Chow S.S. Moses |
| 2005.398 | Effect of Combined CYP2C19 and CYP2D6 Polymorphism On Fluoxetine Pharmacokinetics | Prof. Chow S.S. Moses |
| 2004.028 | Validation of a Five-Drug Cocktail Approach for Predicting Herb-Drug Interactions | Prof. Chow S.S. Moses |
| 2005.309 | Clinical Bioequivalence Study on Two Aspirin Formulations | Prof. Chow S.S. Moses |
| 2006.191 | Clinical Bioequivalence Study on Two Loratadine Formulations | Prof. Chow S.S. Moses |
| 2003.291 | Clinical Bioequivalence Study on Two Enalapril Maleate Formulations(5-mg Lapril vs 5-mg Renitec tablet) | Prof. Chow S.S. Moses |
| 2004.291 | Pharmacokinetic and Pharmacodynamic Effects of a Special Buffered Propranolol Formulation for Sublingual Administration | Prof. Chow S.S. Moses |
| 2005.155 | Clinical Bioequivalence Study on Two Gliclazide Formulations | Prof. Chow S.S. Mossess |
| 2002.074 | A Pharmacokinetic-Genomic Approach for Predicting Herb-Drug Interactions:An Initial Evaluation Using Ginkgo Biloba | Prof. Chow Sing Sum Moses |
| 2006.314 | Bioequivalence Studies on Hydroxychloroquine (BABE-O06-040) | CHOW Sing Sum Moses |
| 2002.422 | Clinical Bioequivalence Study on Two Methyldopa Formulations | Dr. Chow Sing Sum Moses |
| 2006.375 | Clinical Bioequivalence Study on Two Haloperiodol Formulations | CHOW Sing Sum Moses |
| 2006.376 | Clinical Bioequivalence Sutdy on Two Fluconazole Formulations | CHOW Sing Sum Moses |
| 2002.299 | Clinical Bioequivalence Study on Two Lovastatin Formulations | Prof. Chow Sing Sum Moses |
| 2002.300 | Clinical Bioequivalence Study on Paracetamol-Dextropropoxyphene Tablets | Prof. Chow Sing Sum Moses |
| 2002.369 | Clinical Bioequivalence Study on Two Loratadine Formulations | Prof. Chow Sing Sum Moses |
| 2007.141 | Clinical Bioequivalence Study on Two Zolpidem Formulations | Prof. Chow Sing Sum Moses |
| 2006.315 | Pharmacogenetics of Fluoxetine in Chinese Patients (Protocol No. RES-06-01) | CHOW Sing Sum Moses |
| 2002.423 | Clinical Bioequivalence Study on Enalapril Maleate Tablets | Dr. Chow Sing Sum Moses |
Page 10 of 253.